Consistent with this proposal, a search of cancer genomics datasets revealed a co-occurrence of AT-rich interaction domain 1A (ARID1A) mutations with DAXX mutations or copy number alterations in glioma and pancreatic neuroendocrine tumors (PanNETs), among others [82–85]. This evidence concerns the gene ARID1A and central nervous system cancer.